Ontruzant is a Intravenous Kit in the Human Prescription Drug category. It is labeled and distributed by Organon Llc. The primary component is .
Product ID | 78206-148_ca182adf-2c29-47da-9e4e-e86e4b25cc49 |
NDC | 78206-148 |
Product Type | Human Prescription Drug |
Proprietary Name | Ontruzant |
Generic Name | Ontruzant |
Dosage Form | Kit |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2021-06-01 |
Marketing Category | BLA / |
Application Number | BLA761100 |
Labeler Name | Organon LLC |
Active Ingredient Strength | 0 |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-06-01 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0006-5033 | Ontruzant | trastuzumab |
0006-5034 | Ontruzant | Ontruzant |
78206-147 | Ontruzant | trastuzumab |
78206-148 | Ontruzant | Ontruzant |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ONTRUZANT 87405213 not registered Live/Pending |
Merck Sharp & Dohme Corp. 2017-04-10 |
ONTRUZANT 86456110 not registered Dead/Abandoned |
Merck Sharp & Dohme Corp. 2014-11-17 |